WGRX - NASDAQ
Wellgistics Health, Inc.
$0.72
-7.8%Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
At a Glance
Live SnapshotWellgistics Health, Inc. Profit Bridge
Profitability Analysis
Gross Margin
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Operating Margin
Operating losses indicate the core business is unprofitable. Requires restructuring or revenue growth.
Net Profit Margin
Net losses indicate the company is burning cash. Sustainability depends on path to profitability.
Profitability Insight
High margin compression: Large gap between gross and net margins suggests operational inefficiencies or heavy debt burden. Focus on expense management and deleveraging.
Wellgistics Health, Inc. Income Statement
WGRX • NASDAQ
| Wellgistics Health, Inc. Income Statement | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|
REVENUE | |||
18.1M | 0.0 | 32.8M | |
GROSS PROFIT | |||
(16.4M) | (0.0) | (27M) | |
1.8M | 0.0 | 5.7M | |
OPERATING INCOME | |||
(7.9M) | (2.9M) | (9.2M) | |
(6.8M) | (2.9M) | (7.1M) | |
(0.0) | (375.0) | (1.4K) | |
-6.1M | -2.9M | -3.4M | |
PRE-TAX INCOME | |||
(831.5K) | (15.1K) | (287.2K) | |
-831.5K | -15.1K | -287.2K | |
(1.1M) | -375.0 | (2.1M) | |
-711.1K | -15.1K | 678.9K | |
-6.9M | -2.9M | -2.7M | |
NET INCOME | |||
-6.9M | -2.9M | -2.7M |
SEC Filings
WGRX - Filing history and reports
No SEC filings available for WGRX
Related Guides
Continue your WGRX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.